This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbott Laboratories Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mary Kuhns: Innovator in HBV Diagnostics and Therapeutics
Introduction
Mary Kuhns is a prominent inventor based in Abbott Park, Illinois. She has made significant contributions to the field of medical diagnostics and therapeutics, particularly in the area of Hepatitis B virus (HBV) research. Her innovative work has led to the development of methods and products that enhance the understanding and treatment of HBV infections.
Latest Patents
Mary Kuhns holds a patent for "HBV diagnostic, prognostic, and therapeutic methods and products." This patent encompasses compositions, systems, and methods for assessing and monitoring disease stages and phases. It also includes predicting the likelihood of disease progression and monitoring responses to disease therapies in HBV infection. This groundbreaking work is crucial for improving patient outcomes and advancing medical science.
Career Highlights
Throughout her career, Mary has been associated with Abbott Laboratories Corporation, a leading global healthcare company. Her role at Abbott has allowed her to collaborate with other experts in the field and contribute to innovative solutions in healthcare.
Collaborations
Mary has worked alongside notable colleagues such as Gavin A. Cloherty and Ka-Cheung Luk. These collaborations have further enriched her research and development efforts, leading to advancements in HBV diagnostics and therapeutics.
Conclusion
Mary Kuhns is a trailblazer in the field of HBV research, with her patent and work at Abbott Laboratories Corporation showcasing her dedication to improving healthcare. Her contributions are vital for the ongoing fight against HBV and highlight the importance of innovation in medical science.